Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

New predictive biomarkers for ovarian cancer

GA Atallah, NH Abd. Aziz, CK Teik, MN Shafiee… - Diagnostics, 2021 - mdpi.com
Ovarian cancer is the eighth-most common cause of death among women worldwide. In the
absence of distinctive symptoms in the early stages, the majority of women are diagnosed in …

Ovarian cancer stem cells: still an elusive entity?

M Lupia, U Cavallaro - Molecular cancer, 2017 - Springer
The cancer stem cell (CSC) model proposes that tumor development and progression are
fueled and sustained by undifferentiated cancer cells, endowed with self-renewal and tumor …

CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells

M Gil, MP Komorowski, M Seshadri… - The Journal of …, 2014 - journals.aai.org
Signals mediated by the chemokine CXCL12 and its receptor CXCR4 are involved in the
progression of ovarian cancer through enhancement of tumor angiogenesis and …

Ovarian cancer stem cell markers: prognostic and therapeutic implications

D Burgos-Ojeda, BR Rueda, RJ Buckanovich - Cancer letters, 2012 - Elsevier
Cancer stem cells are rare chemotherapy resistant cells within a tumor which can serve to
populate the bulk of a tumor with more differentiated daughter cells and potentially …

Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer

T Velletri, CE Villa, D Cilli, B Barzaghi… - Cell Death & …, 2022 - nature.com
Abstract High Grade Serous Ovarian cancer (HGSOC) is a major unmet need in oncology,
due to its precocious dissemination and the lack of meaningful human models for the …

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells

BJ Winterhoff, M Maile, AK Mitra, A Sebe… - Gynecologic …, 2017 - Elsevier
Objectives The purpose of this study was to determine the level of heterogeneity in high
grade serous ovarian cancer (HGSOC) by analyzing RNA expression in single epithelial …

The role of intra-tumoral heterogeneity and its clinical relevance in epithelial ovarian cancer recurrence and metastasis

CM Roberts, C Cardenas, R Tedja - Cancers, 2019 - mdpi.com
Epithelial ovarian cancer is the deadliest gynecologic cancer, due in large part to recurrent
tumors. Recurrences tend to have metastasized, mainly in the peritoneal cavity and …

Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer

F Ren, J Shen, H Shi, FJ Hornicek, Q Kan… - Biochimica et Biophysica …, 2016 - Elsevier
Ovarian cancer remains the leading cause of gynecological cancer-related mortality despite
the advances in surgical techniques and chemotherapy drugs over the past three decades …

[HTML][HTML] Inhibition of FAK kinase activity preferentially targets cancer stem cells

VN Kolev, WF Tam, QG Wright, SP McDermott… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Because cancer stem cells (CSCs) have been implicated in chemo-resistance, metastasis
and tumor recurrence, therapeutic targeting of CSCs holds promise to address these clinical …